{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.20","value":"26.8"},{"groupId":"OG001","spread":"1.28","value":"26.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"45"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.43","value":"27.1"},{"groupId":"OG001","spread":"1.55","value":"27.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"40"}],"units":"Participants"}],"title":"12 Weeks"}],"denoms":[{"counts":[{"groupId":"OG000","value":"72"},{"groupId":"OG001","value":"62"}],"units":"Participants"}],"description":"Cell proliferation (Ki-67) at baseline and week 12. Ki67 is a cell proliferation associated nuclear protein. It is measured continuously. Higher values are worse.","dispersionType":"Standard Error","groups":[{"description":"Patients receive oral fruit and vegetable extracts twice daily.\n\nfruit and vegetable extracts: Given orally","id":"OG000","title":"Arm I - JuicePlus"},{"description":"Patients receive oral placebo twice daily.\n\nplacebo: Given orally","id":"OG001","title":"Arm II - Control"}],"paramType":"MEAN","populationDescription":"All participants randomized. Not all participants had p27 or Ki67 data so the sample sizes for the primary and secondary analyses differ from the overall sample size.","reportingStatus":"POSTED","timeFrame":"baseline and 12 weeks","title":"Cell Proliferation (Ki-67) at Baseline and Week 12","type":"SECONDARY","unitOfMeasure":"percentage of cells"}